Single-day HER2neu amplification assessment using chip-based digital PCR in formalin-fixed paraffin-embedded breast carcinoma tissue

INTRODUCTION: Human epidermal growth factor receptor 2 (HER2) amplification is present in almost 15%–20% of breast cancer tumors, making it an important parameter for testing. The present study was designed to evaluate a chip-based digital PCR (dPCR) system for assessing HER2 amplification from form...

Descripción completa

Detalles Bibliográficos
Autores principales: Shah, Parth S, Murarka, Shiva, Joshi, Anupam, Mehta, Bhavna, Parmar, Vipal, Shah, Nidhi, Patel, Khushbu, Sands, Jacob
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6061198/
https://www.ncbi.nlm.nih.gov/pubmed/30087576
http://dx.doi.org/10.2147/BCTT.S161264

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6061198/
https://www.ncbi.nlm.nih.gov/pubmed/30087576
http://dx.doi.org/10.2147/BCTT.S161264

Ejemplares similares